Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial.
Bourhis J, Lapeyre M, Tortochaux J, Lusinchi A, Etessami A, Ducourtieux M, Geoffrois L, Domenge C, Verrelle P, Wibault P, Janot F, Temam S, Blanchard P, Tao YG, Auperin A. Bourhis J, et al. Among authors: domenge c. Radiother Oncol. 2011 Jul;100(1):56-61. doi: 10.1016/j.radonc.2011.07.006. Epub 2011 Aug 8. Radiother Oncol. 2011. PMID: 21831465 Clinical Trial.
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
Wibault P, Bensmaine MA, de Forni M, Armand JP, Tellez Bernal E, Guillot T, Recondo G, Domenge C, Janot F, Borel C, Luboinski B, Eschwege F, Cvitkovic E. Wibault P, et al. Among authors: domenge c. J Clin Oncol. 1996 Apr;14(4):1192-200. doi: 10.1200/JCO.1996.14.4.1192. J Clin Oncol. 1996. PMID: 8648374 Clinical Trial.
Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R, Bourhis J, Domenge C, Wibault P, Koscielny S, Lusinchi A, Mamelle G, Janot F, Julieron M, Leridant AM, Marandas P, Armand JP, Schwaab G, Luboinski B, Eschwege F. De Crevoisier R, et al. Among authors: domenge c. J Clin Oncol. 1998 Nov;16(11):3556-62. doi: 10.1200/JCO.1998.16.11.3556. J Clin Oncol. 1998. PMID: 9817275 Clinical Trial.
Phase II study of mitozolomide (M & B 39,565) in head and neck cancer.
Herait P, Armand JP, Benahmed M, Domenge C, Fontana X, Recondo G, Cvitkovic E, Delgado FM. Herait P, et al. Among authors: domenge c. Med Oncol Tumor Pharmacother. 1989;6(4):267-9. doi: 10.1007/BF02985159. Med Oncol Tumor Pharmacother. 1989. PMID: 2615530
60 results